Bacterial Respiratory Infections in Cats: Etiology, Diagnosis, and Treatment

Introduction

Bacterial respiratory infections in cats represent a significant component of feline clinical practice, often occurring as primary pathogens or as secondary invaders following viral compromise of the respiratory epithelium [1]. The feline respiratory tract, from the nasal cavity to the alveoli, is continuously exposed to environmental microorganisms, and the integrity of the mucociliary apparatus, secretory immunoglobulin A, and alveolar macrophages is critical for maintaining sterility in the lower airways [2]. Disruption of these defenses, most commonly by feline herpesvirus type 1 (FHV-1) or feline calicivirus (FCV), creates a permissive environment for bacterial colonization and proliferation [3]. This article provides a detailed examination of the etiology, epidemiology, clinical presentation, diagnostic methodologies, therapeutic strategies, and control measures for bacterial respiratory infections in cats.

Etiology

The primary bacterial pathogens implicated in feline respiratory disease include Bordetella bronchiseptica, Chlamydia felis, and Mycoplasma felis [4]. Other opportunistic bacteria, such as Pasteurella multocida, Streptococcus spp., Staphylococcus spp., and Escherichia coli, are frequently isolated from cases of secondary bacterial pneumonia, particularly in kittens and immunocompromised adults [5].

Bordetella bronchiseptica

Bordetella bronchiseptica is a Gram-negative, aerobic coccobacillus that colonizes the ciliated respiratory epithelium [6]. It is a primary pathogen in cats and a common component of the feline upper respiratory tract infection (URTI) complex [7]. The bacterium produces several virulence factors, including filamentous hemagglutinin, pertactin, and a dermonecrotic toxin, which facilitate adherence to ciliated cells and disruption of mucociliary clearance [8]. Bordetella bronchiseptica is also a zoonotic agent, capable of causing respiratory disease in immunocompromised humans, though transmission from cats to humans is considered rare [9].

Chlamydia felis

Chlamydia felis is an obligate intracellular Gram-negative bacterium that primarily causes conjunctivitis in cats [10]. It is a significant cause of feline URTD, particularly in multi-cat environments such as shelters and catteries [11]. The organism infects epithelial cells of the conjunctiva and upper respiratory mucosa, leading to a neutrophilic inflammatory response [12]. Systemic infection is uncommon, and the organism is typically confined to mucosal surfaces [13].

Mycoplasma felis

Mycoplasma felis is a cell wall-deficient bacterium belonging to the class Mollicutes [14]. It is a commensal of the feline upper respiratory tract and conjunctiva but can act as an opportunistic pathogen, particularly in the context of concurrent viral infection or immunosuppression [15]. Mycoplasma felis is frequently isolated from cats with conjunctivitis and chronic upper respiratory signs [16]. Its lack of a cell wall renders it intrinsically resistant to beta-lactam antimicrobials [17].

Opportunistic and Secondary Bacterial Pathogens

In cases of viral pneumonia or aspiration pneumonia, a mixed bacterial flora is often cultured [18]. Common isolates include Pasteurella multocida, a Gram-negative coccobacillus that is part of the normal oral and upper respiratory flora [19]. Streptococcus canis and Staphylococcus pseudintermedius are Gram-positive cocci that can cause suppurative bronchopneumonia [20]. Escherichia coli and other Enterobacteriaceae are frequently isolated from cats with severe, necrotizing pneumonia, often associated with sepsis [21].

Epidemiology

Bacterial respiratory infections in cats are most prevalent in environments with high population density, poor ventilation, and stress, such as animal shelters, boarding facilities, and multi-cat households [22]. Young kittens, particularly those between 2 and 12 weeks of age, are at the highest risk due to their immature immune systems [23]. Stress factors including weaning, transport, vaccination, and concurrent disease significantly increase susceptibility to bacterial colonization [24].

Transmission occurs primarily via direct contact with infected respiratory secretions, fomites, and aerosolized droplets [25]. Bordetella bronchiseptica is highly contagious and can be shed for weeks to months after clinical recovery, contributing to endemic infection in group housing [26]. Chlamydia felis is also highly contagious, with a short incubation period of 3 to 10 days [27]. Mycoplasma felis is less contagious but can be transmitted through close contact [28].

Clinical Signs

Clinical signs of bacterial respiratory infections in cats are variable and depend on the specific pathogen, the site of infection, and the host immune status [29].

Upper Respiratory Tract Infection (URTI)

The classic presentation of feline URTI includes serous to mucopurulent nasal discharge, sneezing, conjunctivitis, ocular discharge, and lethargy [30]. Cats infected with Bordetella bronchiseptica often exhibit a prominent, paroxysmal cough, which is less common in viral URTI [31]. Chlamydia felis typically causes severe, chemotic conjunctivitis with serous to mucopurulent ocular discharge, often without significant nasal involvement [32]. Mycoplasma felis is associated with chronic conjunctivitis and mild sneezing [33].

Lower Respiratory Tract Infection (LRTI) and Pneumonia

Bacterial pneumonia in cats presents with tachypnea, dyspnea, productive cough, fever, and lethargy [34]. Auscultation may reveal crackles, wheezes, and dullness over consolidated lung lobes [35]. Cats with severe pneumonia may exhibit open-mouth breathing, cyanosis, and signs of systemic inflammatory response syndrome (SIRS) [36]. Aspiration pneumonia, often secondary to megaesophagus or laryngeal dysfunction, presents with acute onset of respiratory distress and fever [37].

Pathology

Gross pathological findings in bacterial pneumonia include cranioventral consolidation of the lung lobes, which are firm, dark red, and fail to collapse [38]. Histologically, suppurative bronchopneumonia is characterized by an influx of neutrophils and macrophages into the alveoli and bronchioles, with fibrin exudation and necrosis of alveolar walls [39]. In Bordetella bronchiseptica infection, there is a characteristic purulent bronchiolitis with peribronchiolar lymphoid hyperplasia [40]. Chlamydia felis infection results in a neutrophilic and lymphoplasmacytic conjunctivitis with epithelial cell hyperplasia and intracytoplasmic inclusion bodies [41].

Diagnosis

A definitive diagnosis of bacterial respiratory infection in cats requires a combination of clinical assessment, diagnostic imaging, and laboratory testing [42].

Clinical Examination and History

A thorough history should include vaccination status, exposure to other cats, onset and duration of clinical signs, and response to prior therapy [43]. Physical examination should focus on the respiratory tract, including auscultation of the thorax, assessment of nasal airflow, and evaluation of the conjunctiva [44].

Diagnostic Imaging

Thoracic radiography is essential for the diagnosis of lower respiratory tract disease [45]. Two-view (lateral and ventrodorsal) radiographs are standard. Bacterial pneumonia typically presents as an alveolar pattern with air bronchograms in the cranioventral lung lobes [46]. A bronchial pattern may be seen in chronic bronchitis. Radiography is also useful for identifying foreign bodies, masses, or pleural effusion [47].

Cytology and Culture

Samples for cytology and bacterial culture can be obtained via nasal swabs, conjunctival swabs, oropharyngeal swabs, transtracheal wash (TTW), or bronchoalveolar lavage (BAL) [48]. For lower respiratory tract infections, BAL is the preferred method, as it samples the alveolar space directly [49]. Cytological evaluation of BAL fluid should include a total nucleated cell count and differential. A neutrophilic predominance with intracellular bacteria is highly suggestive of bacterial pneumonia [50].

Bacterial culture and antimicrobial susceptibility testing (AST) are critical for guiding therapy, particularly in cases of recurrent or refractory infection [51]. Samples should be submitted for aerobic culture. Mycoplasma species require specialized culture media and are not detected on routine aerobic culture [52].

Molecular Diagnostics

Polymerase chain reaction (PCR) assays are highly sensitive and specific for the detection of Bordetella bronchiseptica, Chlamydia felis, and Mycoplasma felis [53]. Real-time PCR (qPCR) allows for quantification of bacterial load. PCR is particularly useful for detecting Chlamydia felis and Mycoplasma felis, which are difficult to culture [54]. Multiplex PCR panels that simultaneously detect FHV-1, FCV, Bordetella bronchiseptica, Chlamydia felis, and Mycoplasma felis are commercially available and are the standard of care for diagnosing feline URTD [55].

Serology

Serological testing for Chlamydia felis and Bordetella bronchiseptica is available but is of limited diagnostic value due to the high prevalence of antibodies in the population and the inability to distinguish active infection from prior exposure [56].

flowchart TD
    A[Cat with Respiratory Signs], > B{Clinical Examination}
    B, > C[Upper Respiratory Signs]
    B, > D[Lower Respiratory Signs]
    C, > E[Conjunctival / Nasal Swab]
    D, > F[Thoracic Radiographs]
    F, > G[Alveolar Pattern?]
    G, >|Yes| H[BAL or TTW]
    G, >|No| I[Consider Bronchial Disease]
    E, > J[Multiplex PCR Panel]
    H, > K[Cytology & Aerobic Culture + AST]
    J, > L[Positive for Bacteria?]
    K, > M[Neutrophilic Inflammation & Intracellular Bacteria?]
    L, >|Yes| N[Targeted Antimicrobial Therapy]
    M, >|Yes| N
    L, >|No| O[Consider Viral Etiology]
    M, >|No| P[Consider Non-Infectious Cause]

Treatment

The cornerstone of treatment for bacterial respiratory infections in cats is appropriate antimicrobial therapy, supported by ancillary care [57].

Antimicrobial Therapy

Selection of an antimicrobial agent should ideally be based on culture and AST results [58]. Empirical therapy is often initiated while awaiting results, particularly in acutely ill cats.

Table 1: Commonly Used Antimicrobials for Feline Bacterial Respiratory Infections

Doxycycline is the drug of choice for empirical treatment of feline URTD due to its efficacy against Bordetella bronchiseptica, Chlamydia felis, and Mycoplasma felis [59]. It is administered orally at 5-10 mg/kg every 12 hours or 10 mg/kg every 24 hours [60]. Doxycycline should be administered with food or water to reduce the risk of esophagitis [61].

For bacterial pneumonia, initial therapy often involves a combination of a beta-lactam (e.g., ampicillin) and a fluoroquinolone (e.g., marbofloxacin) to provide broad-spectrum coverage [62]. Once AST results are available, therapy should be narrowed to the most appropriate agent [63].

Ancillary and Supportive Care

Supportive care is critical for recovery [64]. This includes:

• Nebulization and coupage: Saline nebulization helps liquefy secretions, followed by gentle chest coupage to facilitate expectoration [65].
• Oxygen therapy: For hypoxemic cats, provided via an oxygen cage or nasal cannula [66].
• Fluid therapy: Intravenous crystalloids are indicated for dehydrated or septic cats [67].
• Nutritional support: Appetite stimulants or assisted feeding (nasoesophageal tube) may be necessary in anorexic cats [68].
• Airway clearance: In severe cases, suctioning of the airways may be required [69].

Duration of Therapy

The duration of antimicrobial therapy should be guided by clinical response [70]. For URTD, a minimum of 7-10 days is recommended [71]. For bacterial pneumonia, therapy should continue for at least 2-4 weeks, and radiographs should be repeated to confirm resolution [72]. Premature discontinuation of therapy is a common cause of relapse [73].

Control and Prevention

Control of bacterial respiratory infections in cats relies on management practices that reduce stress and pathogen transmission [74].

Vaccination

Vaccines are available for Bordetella bronchiseptica (intranasal) and Chlamydia felis (injectable) [75]. The Bordetella vaccine is recommended for cats in high-risk environments [76]. The Chlamydia vaccine is considered non-core but may be used in catteries with endemic infection [77]. Neither vaccine provides complete protection but reduces the severity of clinical disease [78].

Environmental Management

In shelters and catteries, the following measures are critical:

• Isolation: New arrivals should be quarantined for at least 14 days [79].
• Ventilation: Adequate air exchange reduces aerosolized pathogen load [80].
• Disinfection: Sodium hypochlorite (bleach) at a 1:32 dilution is effective against Bordetella and Chlamydia [81]. Quaternary ammonium compounds are also effective [82].
• Reducing stress: Minimizing handling, providing hiding boxes, and using synthetic feline facial pheromones can reduce stress-induced immunosuppression [83].

Antimicrobial Stewardship

Judicious use of antimicrobials is essential to mitigate the development of antimicrobial resistance (AMR) [84]. Culture and AST should be performed whenever possible [85]. The use of critically important antimicrobials for human medicine, such as fluoroquinolones and third-generation cephalosporins, should be reserved for cases where no alternative exists [86].

Conclusion

Bacterial respiratory infections in cats are a multifactorial disease complex involving primary pathogens such as Bordetella bronchiseptica, Chlamydia felis, and Mycoplasma felis, as well as secondary opportunistic bacteria. Accurate diagnosis requires a combination of clinical examination, diagnostic imaging, cytology, culture, and molecular testing. Treatment is centered on targeted antimicrobial therapy guided by AST, supported by aggressive ancillary care. Prevention through vaccination, environmental management, and antimicrobial stewardship is essential for controlling these infections in both individual patients and populations.

References

[1] Greene CE. Infectious Diseases of the Dog and Cat. 4th ed. Elsevier Saunders; 2012.

[2] Merck Veterinary Manual. 11th ed. Merck & Co.; 2016.

[3] Gaskell R, Dawson S, Radford A. Feline respiratory disease. In: Greene CE, editor. Infectious Diseases of the Dog and Cat. 4th ed. Elsevier Saunders; 2012. p. 151-162.

[4] Binns SH, Dawson S, Speakman AJ, et al. A study of feline upper respiratory tract disease with reference to prevalence and risk factors for infection with feline calicivirus and feline herpesvirus. J Feline Med Surg. 2000;2(3):123-133.

[5] Helps CR, Lait P, Damhuis A, et al. Factors associated with upper respiratory tract disease caused by feline herpesvirus, feline calicivirus, Chlamydophila felis and Bordetella bronchiseptica in cats: experience from 218 European catteries. Vet Rec. 2005;156(21):669-673.

[6] Foley JE, Rand C, Bannasch MJ, et al. Molecular epidemiology of feline bordetellosis in two animal shelters in California, USA. Prev Vet Med. 2002;54(2):141-156.

[7] Welsh RD. Bordetella bronchiseptica infections in cats. J Am Vet Med Assoc. 1996;209(3):580-584.

[8] Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev. 2005;18(2):326-382.

[9] Register KB, Sukumar N, Palavecino EL, et al. Bordetella bronchiseptica in a pediatric cystic fibrosis patient: a case report and review of the literature. J Clin Microbiol. 2012;50(7):2503-2505.

[10] Sykes JE. Feline chlamydiosis. Clin Tech Small Anim Pract. 2005;20(4):231-234.

[11] Wills JM, Gruffydd-Jones TJ, Howard PE, et al. Prevalence of Chlamydia psittaci in different cat populations in Britain. J Small Anim Pract. 1988;29(6):327-339.

[12] Shewen PE. Chlamydial infection in animals: a review. Can Vet J. 1980;21(1):2-11.

[13] TerWee J, Sabara M, Kokjohn K, et al. Characterization of the systemic disease and ocular signs induced by experimental infection with Chlamydia psittaci in cats. Vet Microbiol. 1998;59(4):259-281.

[14] Brown DR, Zacher LA, Farmerie WG. Spiroplasma and Mycoplasma. In: Gyles CL, Prescott JF, Songer JG, et al., editors. Pathogenesis of Bacterial Infections in Animals. 4th ed. Wiley-Blackwell; 2010. p. 537-556.

[15] Haesebrouck F, Devriese LA, van Rijssen B, et al. Incidence and significance of isolation of Mycoplasma felis from conjunctival swabs of cats. Vet Rec. 1991;128(4):83-85.

[16] Low HC, Powell CC, Veir JK, et al. Prevalence of feline herpesvirus 1, Chlamydophila felis, and Mycoplasma spp DNA in conjunctival cells from cats with and without conjunctivitis. Am J Vet Res. 2007;68(6):643-648.

[17] Taylor-Robinson D, Bébéar C. Antibiotic susceptibilities of mycoplasmas and treatment of mycoplasmal infections. J Antimicrob Chemother. 1997;40(5):623-630.

[18] Macdonald ES, Norris CR, Berghaus RB, et al. Clinicopathologic and radiographic features and etiologic agents in cats with histologically confirmed infectious pneumonia: 39 cases (1991-2000). J Am Vet Med Assoc. 2003;223(8):1142-1150.

[19] Dabo SM, Taylor JD, Confer AW. Pasteurella multocida and bovine respiratory disease. Anim Health Res Rev. 2007;8(2):129-150.

[20] Weese JS, van Duijkeren E. Methicillin-resistant Staphylococcus aureus and Staphylococcus pseudintermedius in veterinary medicine. Vet Microbiol. 2010;140(3-4):418-429.

[21] Brady CA, Otto CM. Systemic inflammatory response syndrome, sepsis, and multiple organ dysfunction syndrome in dogs and cats. In: Bonagura JD, Twedt DC, editors. Kirk's Current Veterinary Therapy XV. Elsevier Saunders; 2014. p. 72-76.

[22] Dinnage JD, Scarlett JM, Richards JR. Descriptive epidemiology of feline upper respiratory tract disease in an animal shelter. J Feline Med Surg. 2009;11(10):816-825.

[23] Edwards DS, Coyne KP, Dawson S, et al. Risk factors for feline upper respiratory tract disease in UK rescue shelters. Vet Rec. 2008;163(22):655-659.

[24] Gourkow N, Phillips CJC. Effect of interactions with humans on behaviour, mucosal immunity and upper respiratory disease of shelter cats. Appl Anim Behav Sci. 2015;169:68-76.

[25] Lappin MR. Feline upper respiratory disease. In: Bonagura JD, Twedt DC, editors. Kirk's Current Veterinary Therapy XV. Elsevier Saunders; 2014. p. 1267-1272.

[26] Coutts AJ, Dawson S, Binns S, et al. Studies on natural transmission of Bordetella bronchiseptica in cats. Vet Microbiol. 1996;48(1-2):19-27.

[27] Sykes JE, Studdert VP, Browning GF. Detection and strain differentiation of feline Chlamydia psittaci by polymerase chain reaction. Vet Microbiol. 1997;55(1-4):259-265.

[28] Tan RJS. Susceptibility of kittens to Mycoplasma felis infection. Jpn J Vet Sci. 1974;36(5):401-406.

[29] Bannasch MJ, Foley JE. Epidemiologic evaluation of multiple respiratory pathogens in cats in animal shelters. J Feline Med Surg. 2005;7(2):109-119.

[30] Gaskell RM, Povey RC. Transmission of feline viral rhinotracheitis. Vet Rec. 1982;111(16):359-362.

[31] Willoughby K, Dawson S, Jones RC, et al. Isolation of Bordetella bronchiseptica from kittens with pneumonia in a breeding cattery. Vet Rec. 1991;129(18):407-408.

[32] Sykes JE. Feline chlamydial conjunctivitis. In: Bonagura JD, Twedt DC, editors. Kirk's Current Veterinary Therapy XV. Elsevier Saunders; 2014. p. 1273-1276.

[33] Hartmann AD, Hawley J, Werckenthin C, et al. Detection of bacterial and viral organisms from the conjunctiva of cats with conjunctivitis and upper respiratory tract disease. J Feline Med Surg. 2010;12(10):775-782.

[34] Foster SF, Martin P, Braddock JA, et al. A retrospective analysis of feline bronchoalveolar lavage cytology and microbiology (1995-2000). J Feline Med Surg. 2004;6(3):189-198.

[35] Hawkins EC. Bronchoalveolar lavage. In: King LG, editor. Textbook of Respiratory Disease in Dogs and Cats. Elsevier Saunders; 2004. p. 118-128.

[36] DeClue AE, Cohn LA. Sepsis in dogs and cats. Vet Clin North Am Small Anim Pract. 2007;37(4):697-716.

[37] Farrow CS. Aspiration pneumonia in the dog and cat. Vet Clin North Am Small Anim Pract. 1985;15(5):1009-1021.

[38] Caswell JL, Williams KJ. Respiratory system. In: Maxie MG, editor. Jubb, Kennedy, and Palmer's Pathology of Domestic Animals. 6th ed. Elsevier; 2016. p. 465-591.

[39] López A. Respiratory system, thoracic cavity, and pleura. In: Zachary JF, McGavin MD, editors. Pathologic Basis of Veterinary Disease. 5th ed. Elsevier; 2012. p. 458-538.

[40] Bemis DA, Greisen HA, Appel MJ. Pathogenesis of canine bordetellosis. J Infect Dis. 1977;135(5):753-762.

[41] Pospischil A, Thoma R, Hilbe M, et al. Abortion in women caused by Chlamydia psittaci: a case report and review of the literature. J Vet Med B Infect Dis Vet Public Health. 2002;49(4):189-192.

[42] Lappin MR, Blondeau J, Boothe D, et al. Antimicrobial use guidelines for treatment of respiratory tract disease in dogs and cats: antimicrobial guidelines working group of the International Society for Companion Animal Infectious Diseases. J Vet Intern Med. 2017;31(2):279-294.

[43] Sparkes AH. Feline upper respiratory tract disease. In: Chandler EA, Gaskell CJ, Gaskell RM, editors. Feline Medicine and Therapeutics. 3rd ed. Blackwell Publishing; 2004. p. 345-362.

[44] Rozanski EA, Rush JE. Respiratory emergencies. In: King LG, editor. Textbook of Respiratory Disease in Dogs and Cats. Elsevier Saunders; 2004. p. 479-490.

[45] Thrall DE. Textbook of Veterinary Diagnostic Radiology. 6th ed. Elsevier Saunders; 2013.

[46] Suter PF, Lord PF. Thoracic Radiography: A Text Atlas of Thoracic Diseases of the Dog and Cat. Wettswil: Suter; 1984.

[47] Johnson LR. Clinical Canine and Feline Respiratory Medicine. Wiley-Blackwell; 2010.

[48] Hawkins EC. Diagnostic tests for the lower respiratory tract. In: King LG, editor. Textbook of Respiratory Disease in Dogs and Cats. Elsevier Saunders; 2004. p. 129-140.

[49] Hawkins EC, DeNicola DB, Kuehn NF. Bronchoalveolar lavage in the evaluation of pulmonary disease in the dog and cat. J Vet Intern Med. 1990;4(5):267-274.

[50] Cowell RL, Tyler RD, Meinkoth JH, et al. Diagnostic Cytology and Hematology of the Dog and Cat. 3rd ed. Mosby Elsevier; 2008.

[51] Boothe DM. Principles of antimicrobial therapy. Vet Clin North Am Small Anim Pract. 2006;36(5):1003-1047.

[52] Waites KB, Bébéar CM, Robertson JA, et al. Cumitech 34: Laboratory Diagnosis of Mycoplasmal Infections. American Society for Microbiology; 2001.

[53] Helps CR, Harbour DA. Comparison of a commercial polymerase chain reaction test kit with conventional methods for the detection of Chlamydia psittaci in feline conjunctival swabs. Vet Rec. 1997;141(12):310-311